Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide

K.A. van Nifterik; J. Berg; W.F. van der Meide; N. Ameziane; L.E. Wedekind; R.D.M. Steenbergen; S. Leenstra; M.V.M. Lafleur; B.J. Slotman; L.J.A. Stalpers; P. Sminia

doi:10.1038/sj.bjc.6605712

Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide

K.A. van Nifterik, J. Berg, W.F. van der Meide, N. Ameziane, L.E. Wedekind, R.D.M. Steenbergen, S. Leenstra, M.V.M. Lafleur, B.J. Slotman, L.J.A. Stalpers, P. Sminia

Research output: Contribution to journal › Article › Academic › peer-review

70 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	29-35
Journal	British Journal of Cancer
Volume	103
Issue number	1
DOIs	https://doi.org/10.1038/sj.bjc.6605712
Publication status	Published - 2010

Access to Document

10.1038/sj.bjc.6605712

257667Final published version, 413 KB

Cite this

van Nifterik, K. A., Berg, J., van der Meide, W. F., Ameziane, N., Wedekind, L. E., Steenbergen, R. D. M., Leenstra, S., Lafleur, M. V. M., Slotman, B. J., Stalpers, L. J. A., & Sminia, P. (2010). Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide. British Journal of Cancer, 103(1), 29-35. https://doi.org/10.1038/sj.bjc.6605712

van Nifterik, K.A. ; Berg, J. ; van der Meide, W.F. ; Ameziane, N. ; Wedekind, L.E. ; Steenbergen, R.D.M. ; Leenstra, S. ; Lafleur, M.V.M. ; Slotman, B.J. ; Stalpers, L.J.A. ; Sminia, P. / Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide. In: British Journal of Cancer. 2010 ; Vol. 103, No. 1. pp. 29-35.

@article{4ba9c3bffc4649f296ed54e6b9773465,

title = "Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide",

author = "{van Nifterik}, K.A. and J. Berg and {van der Meide}, W.F. and N. Ameziane and L.E. Wedekind and R.D.M. Steenbergen and S. Leenstra and M.V.M. Lafleur and B.J. Slotman and L.J.A. Stalpers and P. Sminia",

year = "2010",

doi = "10.1038/sj.bjc.6605712",

language = "Undefined/Unknown",

volume = "103",

pages = "29--35",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "1",

}

van Nifterik, KA, Berg, J, van der Meide, WF, Ameziane, N, Wedekind, LE, Steenbergen, RDM, Leenstra, S, Lafleur, MVM, Slotman, BJ, Stalpers, LJA & Sminia, P 2010, 'Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide', British Journal of Cancer, vol. 103, no. 1, pp. 29-35. https://doi.org/10.1038/sj.bjc.6605712

Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide. / van Nifterik, K.A.; Berg, J.; van der Meide, W.F.; Ameziane, N.; Wedekind, L.E.; Steenbergen, R.D.M.; Leenstra, S.; Lafleur, M.V.M.; Slotman, B.J.; Stalpers, L.J.A.; Sminia, P.

In: British Journal of Cancer, Vol. 103, No. 1, 2010, p. 29-35.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide

AU - van Nifterik, K.A.

AU - Berg, J.

AU - van der Meide, W.F.

AU - Ameziane, N.

AU - Wedekind, L.E.

AU - Steenbergen, R.D.M.

AU - Leenstra, S.

AU - Lafleur, M.V.M.

AU - Slotman, B.J.

AU - Stalpers, L.J.A.

AU - Sminia, P.

PY - 2010

Y1 - 2010

U2 - 10.1038/sj.bjc.6605712

DO - 10.1038/sj.bjc.6605712

M3 - Article

C2 - 20517307

VL - 103

SP - 29

EP - 35

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 1

ER -